VOLUME 26 ISSUES 1 | 2024

The impact of passive alveolor molding vs. nasoalveolar molding on cleft width and other parameters of maxilllary growth in unilateral cleft lip palate

1Muhammad Afaq Kabir, 2Huma Azam, 3Farda Ur Rehman, 4Kaynat Anwar, 5Ammara Rafi, 6Safoora Khalil

1Divisional headquarter and teaching hospital Mirpur
2Dhq teaching hospital Mirpur AJ&K
3DHQ mirpur Azad Jammu and Kashmir
4Dhq teaching Hospital Mirpur A.J.K
5DHQ Hospital Mirpur AJK
6Sheikh khalifa bin Zayd Hospital Muzaffarabad

Abstract
Background: Unilateral cleft lip and palate (UCLP) is a congenital anomaly that affects the facial structures, particularly the maxillary region. The worldwide prevalence of the UCL/P is 0.5-3 cases for each 1000 births.
Objective: The basic aim of the study is to compare the effects of passive alveolar molding (PAM) and nasoalveolar molding (NAM) on cleft width and various parameters of maxillary growth in unilateral cleft lip palate.
Methods: Forty-five infants diagnosed with unilateral cleft lip palate were included in the study. They were divided into two groups based on the selected treatment approach: PAM and NAM. Cleft width measurements were recorded at specific time intervals during the treatment period. Additionally, maxillary growth parameters, including maxillary arch width, nasal symmetry, and columellar length, were evaluated over the course of the follow-up period.
Results: Data was collected from 45 infant patients. There were 23 patients in PAM group and 22 patients in Nam group. Mean age was 4.5±2.45 months and there was 20 female patients and 25 male patients. Throughout the treatment period, both PAM and NAM groups exhibited progressive reduction in cleft width.
Conclusion: It is concluded that both PAM and NAM interventions contribute positively to cleft width reduction, maxillary arch width, nasal symmetry, and columellar length. Notably, NAM exhibited superior efficacy in terms of faster cleft width reduction, improved nasal symmetry, and enhanced columellar length when compared to PAM.